Cipla gets 8 observations after FDA inspection at Bengaluru plant
13 Nov 2024 //
CNBCTV
Cipla`s Generics Sodium Thiosulfate Receives Tentative Approval in US
01 Nov 2024 //
FDA
JPMorgan Sees Cipla Stock Upside With Gabraxane FDA Approval
31 Oct 2024 //
INVESTING
Cipla Q2 Profit Rises 15% to Rs 1,303 Cr, Revenue Up 5.6%
30 Oct 2024 //
BUSINESS STD
India`s Cipla beats Q2 profit view on strong US, India demand
29 Oct 2024 //
REUTERS
Cipla, Alkem Laboratories in final lap to buy SMT
16 Oct 2024 //
ECONOMICTIMES
Cipla`s Generics Nicardipine HCl Receives Approval in US
24 Sep 2024 //
FDA
Cipla`s Generics Dihydroergotamine Mesylate Receives Approval in US
20 Sep 2024 //
FDA
Cipla`s Generics Calcitonin Salmon Receives Approval in US
20 Sep 2024 //
FDA
Cipla Vice Chairman MK Hamied Resigns, Son Kamil Hamied Joins the Board
03 Sep 2024 //
ECONOMICTIMES
Cipla expects to commence supplies to US from China plant later this year
28 Jul 2024 //
ECONOMICTIMES
Cipla`s North America business revenue hits record high in Q1 at $250 million
26 Jul 2024 //
ECONOMICTIMES
Cipla gets Rs 773 crore demand notice from I-T department
17 Jul 2024 //
ECONOMIC TIMES
As monsoon sets in, respiratory, malaria drugs see demand rise
08 Jul 2024 //
ECONOMIC TIMES
FDA Issues form 483 to Cipla Goa
26 Jun 2024 //
FDA
Cipla EU to invest an additional € 3 million in Ethris
19 Jun 2024 //
INDIANPHARMAPOST
FDA Issues form 483 to Cipla Ltd.
07 Jun 2024 //
FDA
DoP directs NPPA to recalculate ceiling price of three after Cipla`s petition
03 Jun 2024 //
PHARMABIZ
Indian drugmakers to see FY25 revenue boost in key US market
28 May 2024 //
REUTERS
Cipla receives final approval for the generic version of Somatuline Depot Inj
23 May 2024 //
INDIANPHARMAPOST
Cipla gets USFDA nod to market Lanreotide injection
22 May 2024 //
ECONOMICTIMES
Cipla ups investment in point-of-care testing firm Achira Labs
16 May 2024 //
ECONOMICTIMES
Cipla shares soar 4% after promoter family unloads 2.53% stake
15 May 2024 //
MONEYCONTROL
India`s Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
11 May 2024 //
REUTERS
Cipla beats estimates as Q4 net profit zooms 78% to Rs 939 crore
09 May 2024 //
MONEYCONTROL
USFDA issues Form 483 with 1 inspectional observation to Cipla`s Kurkumbh unit
08 May 2024 //
ECONOMICTIMES
Govt restrictions & Mkg dilemmas: The silent campaigns of Nicotine Gum product
08 May 2024 //
AFAQS
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
06 May 2024 //
REUTERS
Cipla and Glenmark initiate recall of certain products in the US
06 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Amgen reports a 22% increase in Q1 2024 net revenues
03 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Enforcement Report - Week of May 1, 2024
01 May 2024 //
FDA
Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India
28 Apr 2024 //
ECONOMICTIMES
Cipla Health strengthens its play in beauty and personal care
16 Apr 2024 //
INDIANPHARMAPOST
FDA Issues form 483 to Cipla
10 Apr 2024 //
FDA
US FDA`s 6 observations for Cipla`s Patalganga unit drags shares down 1.5%
04 Apr 2024 //
CONTRACT PHARMA
Sanofi India, Cipla join hands to promote CNS products in India
27 Mar 2024 //
BUSINESS STANDARD
Cipla`s Generic Selexipag Receives Approval in the U.S.
11 Mar 2024 //
FDA
Cipla incorporates JV company in USA
02 Mar 2024 //
INDIAN PHARMA POST
Cipla partners with CSIR-CDRI to develop formulation for fungal keratitis
15 Feb 2024 //
ECONOMIC TIMES
Cipla eyes acquisitions, inorganic partnerships in US market
04 Feb 2024 //
ECONOMIC TIMES
Cipla expects record 24 per cent Ebitda margin in FY24
26 Jan 2024 //
ECONOMIC TIMES
Samina Hamied of Cipla steps down from her executive role
26 Jan 2024 //
ECONOMIC TIMES
Cipla posts Q3 FY24 consolidated PAT at Rs. 1,055.90 Cr
23 Jan 2024 //
INDIAN PHARMA POST
Cipla announces joint venture in the United States with Kemwell Biopharma
08 Jan 2024 //
PR NEWSWIRE
Cipla invests Rs 42 crore in digital tech firm GoApptiv
15 Dec 2023 //
ECONOMIC TIMES
Cipla Limited on Health Canada Inspection List
13 Dec 2023 //
HEALTH CANADA
Cipla unit recalls anti-seizure drug because of faulty packaging
12 Dec 2023 //
FIERCE PHARMA
Cipla unit recalls one lot of medication in US due to seal integrity issue
10 Dec 2023 //
ECONOMIC TIMES
Cipla`s Generic Vasopressin Receives Approval in the U.S.
06 Dec 2023 //
FDA
Cipla partners with TEACH to create career opportunities for youth
30 Nov 2023 //
INDIAN PHARMA POST
Cipla`s Generic Darunavir Receives Approval in the U.S.
28 Nov 2023 //
FDA
Cipla Limited Receives FDA Warning Letter
21 Nov 2023 //
FDA
USFDA warns Cipla for lapses in manufacturing practices at Pithampur facility
20 Nov 2023 //
ECONOMIC TIMES
Indian drugmaker Cipla tops Q2 profit view on solid domestic, N.America sales
27 Oct 2023 //
REUTERS
Torrent talks for $7 billion Cipla buyout trip on valuation
24 Oct 2023 //
ECONOMIC TIMES
Cipla shares trade down after FDA inspection at US facility
12 Oct 2023 //
MONEY CONTROL
Cipla falls after US subsidiary receives 5 observations from FDA
21 Sep 2023 //
MONEYCONTROL
Torrent Pharma looks to tie up with CVC Capital to fund Cipla purchase
19 Sep 2023 //
ECONOMIC TIMES
Torrent Pharma looks to tie up with CVC Capital to fund Cipla purchase
15 Sep 2023 //
HEALTH ET
Cipla founding family’s stake sale in jeopardy over $13 billion valuation target
14 Sep 2023 //
ECONOMIC TIMES